4.6 Article

Proof of principle: The predisposition, infection, response, organ failure sepsis staging system

Journal

CRITICAL CARE MEDICINE
Volume 39, Issue 2, Pages 322-327

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/CCM.0b013e3182037a8e

Keywords

septic shock; inflammation

Funding

  1. National Institutes of Health, Bethesda, MD [HL091757, GM076659]
  2. National Institute of General Medical Sciences, Bethesda, MD [GM076652]
  3. Swiss Foundation for Grants in Biology and Medicine, Berne, Switzerland (SSMBS) [PASMP3-127684/1]
  4. Hutchinson Technologies
  5. Eli Lilly
  6. Inverness Medical
  7. Critical Biologics
  8. Swiss National Science Foundation (SNF) [PASMP3-127684] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

Objective: In an effort to improve upon the traditional sepsis syndrome definitions, the predisposition, infection, response, organ dysfunction (PIRO) model was proposed to better characterize sepsis. The objective of this investigation was to derive and validate a sepsis staging system based on the PIRO concept that risk stratifies patients with suspected infection. Design: Three independent, observational, prospective cohorts were studied. A derivation cohort (n = 2,132) was used to create the PIRO score, identifying independent predictors of mortality. Individual values were assigned to create the weighted integer score for each parameter, yielding the final PIRO score. The prognostic performance was then investigated in independent internal (n = 4,618) and external (n = 1,004) validation cohorts. Setting: Two large U. S. tertiary care centers. Patients: Patients admitted to the hospital from the emergency department with suspected infection. Interventions: None. Measurements and Main Results: The PIRO staging system was created by combining components of predisposition (age, chronic obstructive pulmonary disease, liver disease, nursing home residency, and malignancy with and without metastasis), infection (pneumonia and cellulitis), response (tachypnea, bandemia, and tachycardia), and organ dysfunction (renal, respiratory, cardiac, metabolic, and hematologic). The derived PIRO score showed stepwise increase in mortality with increasing points and high discriminatory ability with an area under the curve of 0.90 in the derivation cohort, 0.86 in internal validation, and 0.83 in external validation. Conclusions: This study provides evidence-based support for the PIRO approach to sepsis staging. Future efforts may utilize this approach with additional parameters (e. g., genetics and novel biochemical markers) to develop further the PIRO stratification system. (Crit Care Med 2011; 39: 322-327)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available